Lucid Diagnostics Inc.

NASDAQ:LUCD

0.7643 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -52.666-56.171-28.078-8.28-4.421-1.126
Depreciation & Amortization 2.4991.9360.004000
Deferred Income Tax -5,766.9370-10.472000
Stock Based Compensation 6.82214.9919.5990.0650.1740.08
Change In Working Capital 5.6758.9060.8072.5851.8850.72
Accounts Receivables -0.0280.183-0.2000
Inventory 000000
Accounts Payables 0.089-0.445-0.6651.1460.3020.497
Other Working Capital 5.6149.1681.6721.4391.5830.223
Other Non Cash Items 5,771.790.65310.472-1.081-0.128-0.205
Operating Cash Flow -32.817-29.685-17.668-5.629-2.361-0.114
Investing Activities:
Investments In Property Plant And Equipment -0.221-0.908-0.862000
Acquisitions Net 0-3.20000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 0-3.2-862000
Investing Cash Flow -0.221-4.108-0.862000
Financing Activities:
Debt Repayment 1000000
Common Stock Issued 0.2841.807705.5832.50.132
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 19.1760.8042.0755.5842.50.132
Financing Cash Flow 29.462.61172.0755.5832.50.132
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -3.578-31.18253.545-0.0450.1390.018
Cash At End Of Period 18.89622.47453.6560.1110.1560.018